Acquisition deepens Mesa's commitment to biopharmaceutical quality control and will be the core of its new platform, Biopharmaceutical Development
A targeted tool for researching signaling networks in immunotherapy research
Novel antibody labeling immunoassay technology for multiplex immune profiling addresses one of the fastest growing, billion-dollar life science market sectors
Thermo Fisher Scientific has received FDA clearance for its de novo submission of the QMS Plazomicin Immunoassay
Testing for change in PCT levels assists with antibiotic stewardship and risk assessment of lower respiratory tract infections and sepsis
Immunoassays span the spectrum of analytical biology, from basic research through medical diagnosis.